Chemical Works of Gedeon Richter Plc (RGEDF)
38.55
+0.62
(+1.64%)
USD |
OTCM |
Oct 06, 16:00
Chemical Works of Gedeon Richter Gross Profit Margin (Quarterly) : 70.03% for June 30, 2026
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 70.03% |
| March 31, 2026 | 67.10% |
| December 31, 2025 | 69.63% |
| September 30, 2025 | 66.78% |
| June 30, 2025 | 70.04% |
| March 31, 2025 | 69.26% |
| December 31, 2024 | 68.33% |
| September 30, 2024 | 68.14% |
| June 30, 2024 | 69.25% |
| March 31, 2024 | 69.90% |
| December 31, 2023 | 63.98% |
| September 30, 2023 | 71.61% |
| June 30, 2023 | 63.28% |
| March 31, 2023 | 60.75% |
| December 31, 2022 | 55.26% |
| September 30, 2022 | 59.99% |
| June 30, 2022 | 57.04% |
| March 31, 2022 | 57.12% |
| December 31, 2021 | 55.09% |
| September 30, 2021 | 54.42% |
| June 30, 2021 | 56.59% |
| March 31, 2021 | 55.51% |
| December 31, 2020 | 54.03% |
| September 30, 2020 | 55.81% |
| June 30, 2020 | 57.82% |
| Date | Value |
|---|---|
| March 31, 2020 | 57.00% |
| December 31, 2019 | 54.75% |
| September 30, 2019 | 53.90% |
| June 30, 2019 | 55.42% |
| March 31, 2019 | 56.63% |
| December 31, 2018 | 52.33% |
| September 30, 2018 | 58.12% |
| June 30, 2018 | 58.62% |
| March 31, 2018 | 57.55% |
| December 31, 2017 | 55.29% |
| September 30, 2017 | 57.78% |
| June 30, 2017 | 58.45% |
| March 31, 2017 | 56.02% |
| December 31, 2016 | 54.54% |
| September 30, 2016 | 59.15% |
| June 30, 2016 | 58.00% |
| March 31, 2016 | 59.73% |
| December 31, 2015 | 61.89% |
| September 30, 2015 | 56.07% |
| June 30, 2015 | 63.60% |
| March 31, 2015 | 63.34% |
| December 31, 2014 | 60.28% |
| September 30, 2014 | 58.77% |
| June 30, 2014 | 59.55% |
| March 31, 2014 | 62.51% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| AstraZeneca PLC | 76.09% |
| ANI Pharmaceuticals, Inc. | 54.97% |
| Corcept Therapeutics, Inc. | 98.41% |
| Veru, Inc. | -- |
| Avadel Pharmaceuticals Plc | -- |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | 15.75% |
| Return on Assets | 12.87% |
| Return on Invested Capital | 15.39% |
| Profit Margin (Quarterly) | 15.81% |
| Operating Margin (Quarterly) | 36.60% |
| Return on Net Operating Assets | 18.43% |